Very few investors can match Stanley Druckenmiller.
2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Is Eli Lilly a Buy Before 2026?

11:30am, Tuesday, 16'th Dec 2025
Eli Lilly's next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from obesity-related complications. The company has a diversified portfolio across wei
INDIANAPOLIS , Dec. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025.
Major players in healthcare are increasing their commitments to return capital to shareholders, resulting in significantly higher dividends. Recent dividend announcements from major companies in the
Central Pacific Bank Trust Division boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 25.8% in the undefined quarter, according to the company in its most recent Form 13F filing w
Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday, as the AI/Datacenter rotation trade continues to gather steam during t
GAMMA Investing LLC reduced its position in Eli Lilly and Company (NYSE: LLY) by 4.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Novo Nordisk A/S (NYSE: NVO) stock has plunged around 41% year to date, as per data from Benzinga Pro.
Corient Private Wealth LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 3.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities

2 Predictions for Eli Lilly in 2026

03:30pm, Monday, 15'th Dec 2025
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also looks ripe to announce a stock split.
Eli Lilly & Co. (NYSE: LLY)'s dominance in obesity therapeutics looks increasingly difficult to challenge, and Bank of America believes the market is still underestimating just how much growth lies ah
Eli Lilly's recent long streak of correction for nine trading days calls for a look at the stock even as it has stabilised now. It's explained by stretched valuations and also the lowering of prices o
Eli Lilly's weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market today and has a pipeline of promising candidates to potentially reinforce its
Castleark Management LLC decreased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 42.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the S
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE